Product correctly added to cart.

discount label
GSK3145095
View 3D

Biosynth logo

GSK3145095

CAS: 1622849-43-7

Ref. 3D-XPC84943

10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Tuesday 21 Jan 2025

Product Information

Name:
GSK3145095
Description:

GSK3145095 is a small molecule that has been shown to be active in the treatment of inflammatory diseases and cancer. GSK3145095 is a potent inhibitor of NF-κB, which is an inflammatory mediator and regulator of immune responses. This drug has synergistic effects with other drugs, such as methotrexate, which are used in the treatment of cancer. GSK3145095 shows promise as a potential therapeutic agent for various types of cancers. The drug has been shown to inhibit proliferation and induce apoptosis in cancer cells by targeting the microenvironment of these cells (e.g., tumor blood vessels). GSK3145095 also potently inhibits a broad range of infectious disease agents, including Mycobacterium tuberculosis and human immunodeficiency virus type 1 (HIV-1). Clinical trials are currently underway for this compound to determine its efficacy for the treatment of cancer.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
397.38 g/mol
Formula:
C20H17F2N5O2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-XPC84943 GSK3145095

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".